WILMINGTON–aaiPharma (Nasdaq:AAIIE) has named Timothy R. Wright presidetn of its pharmaceuticals division.
Wright joins the company from Elan Biopharmaceuticals, where he served as president of global commercial operations and helped create and implement Elan’s recovery plan.
Wright held a number of senior management and executive positions with well-known healthcare companies including Cardinal Health and DuPont Merck Pharmaceuticals.
